{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T13:59:12Z","timestamp":1722261552273},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.cmi.2015.11.025","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T01:45:57Z","timestamp":1453254357000},"page":"372-378","source":"Crossref","is-referenced-by-count":14,"title":["Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C"],"prefix":"10.1016","volume":"22","author":[{"given":"C.","family":"Sagnelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Merli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Uberti-Foppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Grandone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Salpietro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Minichini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.M.","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lazzarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sagnelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2015.11.025_bib1","first-page":"423","article-title":"Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease","volume":"37","author":"Armignacco","year":"2014","journal-title":"New Microbiol"},{"key":"10.1016\/j.cmi.2015.11.025_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.qai.0000192001.15777.15","article-title":"Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levels","volume":"41","author":"Uberti-Foppa","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cmi.2015.11.025_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/QAI.0b013e3181cf4d8b","article-title":"Liver histology in HIV\/hepatitis C\u2013coinfected and HCV-monoinfected patients with persistently normal alanine aminotransferases","volume":"54","author":"Sagnelli","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cmi.2015.11.025_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bjid.2013.06.005","article-title":"Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus\/hepatitis C virus coinfected patients","volume":"18","author":"Sagnelli","year":"2014","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.025_bib5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s15010-013-0502-3","article-title":"Factors influencing liver fibrosis and necroinflammation in HIV\/HCV coinfection and HCV monoinfection","volume":"41","author":"Sagnelli","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2015.11.025_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in humanimmunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group","volume":"30","author":"Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2015.11.025_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1053\/jhep.2002.35064","article-title":"Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol","volume":"36","author":"Monto","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2015.11.025_bib8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2893.2011.01481.x","article-title":"Role of hepatitis C virus genotype 3 in liver fibrosis progression\u2014a systematic review and meta-analysis","volume":"18","author":"Probst","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cmi.2015.11.025_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.20805","article-title":"Hepatic steatosis in HIV\/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection","volume":"42","author":"Monto","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2015.11.025_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.aids.0000210606.63138.f5","article-title":"Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors","volume":"20","author":"Bani-Sadr","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.cmi.2015.11.025_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1086\/505495","article-title":"Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients","volume":"43","author":"McGovern","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2015.11.025_bib12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/j.1365-2036.2007.03533.x","article-title":"Hepatic steatosis in HIV-infected patients in France: comparison with HCV-monoinfected patients matched for BMI and genotype","volume":"26","author":"Cast\u00e9ra","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cmi.2015.11.025_bib13","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.22134","article-title":"Steatohepatitis: risk factors and impact on disease severity in human immunodeficiency virus\/hepatitis C virus coinfection","volume":"47","author":"Sterling","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2015.11.025_bib14","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/hep.25791","article-title":"Hepatic steatosis and steatohepatitis in human immunodeficiency virus\/hepatitis C virus\u2013coinfected patients","volume":"56","author":"Mac\u00edas","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2015.11.025_bib15","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"51","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2015.11.025_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/jvh.12053","article-title":"Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C","volume":"20","author":"Zampino","year":"2013","journal-title":"J Viral Hepat"},{"issue":"10","key":"10.1016\/j.cmi.2015.11.025_bib17","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/gutjnl-2014-306997","article-title":"Impact of common risk factors of fibrosis progression in chronic hepatitis C","volume":"64","author":"R\u00fceger","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.cmi.2015.11.025_bib18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/liv.12615","article-title":"Revisiting liver disease progression in HIV\/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3","volume":"35","author":"Mandorfer","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.cmi.2015.11.025_bib19","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/liv.12781","article-title":"TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism","volume":"35","author":"Coppola","year":"2015","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cmi.2015.11.025_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.24350","article-title":"Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C","volume":"54","author":"Tr\u00e9po","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2015.11.025_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.24123","article-title":"Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C","volume":"53","author":"Valenti","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2015.11.025_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2010.12.020","article-title":"Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus\u2013associated steatosis","volume":"55","author":"Cai","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.cmi.2015.11.025_bib23","doi-asserted-by":"crossref","first-page":"e81312","DOI":"10.1371\/journal.pone.0081312","article-title":"No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV","volume":"8","author":"Nakamura","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.11.025_bib24","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jhep.2011.10.024","article-title":"Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients","volume":"56","author":"Valenti","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cmi.2015.11.025_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep.26758","article-title":"Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C","volume":"59","author":"Dunn","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2015.11.025_bib26","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/135965350801300801","article-title":"HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3","volume":"13","author":"Borghi","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cmi.2015.11.025_bib27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ajg.2014.32","article-title":"Risk factors for fatty liver in the Multicenter AIDS Cohort Study","volume":"109","author":"Price","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cmi.2015.11.025_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2559.2001.01208.x","article-title":"Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3","volume":"39","author":"Rubbia-Brandt","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.cmi.2015.11.025_bib29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/j.gastro.2010.11.052","article-title":"Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus","volume":"140","author":"Woreta","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmi.2015.11.025_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.23619","article-title":"Hepatic steatosis in patients coinfected with human immunodeficiency virus\/hepatitis C virus: a meta-analysis of the risk factors","volume":"52","author":"Machado","year":"2010","journal-title":"Hepatology"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X16000070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X16000070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:08:23Z","timestamp":1654128503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X16000070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1198743X16000070"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2015.11.025","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}